In this study, we established that CEA/CK/CD133 mRNA detection of tumor drainage vein blood is a useful tool for the determination of high risk patients with Dukes' stage B and C who are in need of postoperative adjuvant therapy. This evidence concerns the gene CEACAM5 and neoplasm.